Challenges and Opportunities in Post‐Marketing Reporting of Factor VIII Inhibitors With Efanesoctocog Alfa
Authors
- Sriya Gunawardena (ORCID: https://orcid.org/0000-0003-3232-6913)
- Graham Neill
- Jennifer Dumont (ORCID: https://orcid.org/0000-0002-1710-7109)
- Linda Bystrická (ORCID: https://orcid.org/0000-0002-9787-7866)
- Mahnouch Georget
- Elena Santagostino
Institutions
- Morristown Medical Center (US)
- Sanofi (United States) (US)
- C3I (United States) (US)
- Swedish Orphan Biovitrum (Sweden) (SE)
- Sanofi (United Kingdom) (GB)
Publication Details
- Journal
- Haemophilia
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1111/hae.70250
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00